Sarofim Fayez’s AbbVie ABBV Stock Holding History

Sarofim Fayez’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	$254M	Buy	+5,672,880	New	+$251M	1.24%	30

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sarofim Fayez's ABBV Position: Q3 2013 in Review

Sarofim Fayez opened a new position in AbbVie (ABBV) in Q3 2013: 5,672,880 shares worth $254M. The stake represents 1.24% of the portfolio and ranks #30 among its holdings.

1,297 funds tracked by Wall St. Rank hold ABBV as of Q3 2013.

Sarofim Fayez held 5,672,880 shares of AbbVie worth $254M as of Q3 2013.
AbbVie was a new Sarofim Fayez position in Q3 2013.
AbbVie made up 1.24% of Sarofim Fayez's portfolio in Q3 2013, its #30 holding.
1,297 funds tracked by Wall St. Rank held AbbVie as of Q3 2013.

Based on Sarofim Fayez's 13F filing for Q3 2013, filed 14 Nov 2013.